Teva Reports Spike In Q3/2014 Profits

November 2, 2014 | The Israeli pharmaceutical company Teva Pharmaceutical released its third quarter results, reporting a non-GAAP profit of $1.1 billion. The profit is six percent higher than the corresponding quarter of last year. Based on GAAP, Teva made a net profit of $876 million ($1.02 per share), compared to $711 million ($0.84 per share) in the third quarter of 2013. “The effort we have put forth thus far in 2014 towards solidifying our foundation to drive organic growth is reflected in our strong third quarter results,” said Teva CEO Erez Vigodman. Teva was founded in 1901 and ranks among the top 10 pharmaceutical companies in the world.